-
Medicure Reports Financial Results for Quarter Ended June 30, 2024
14 Aug 2024 21:15 GMT
… Medicure Inc.
Medicure is a company focused on the development and commercialization of pharmaceuticals … clinical trials and obtaining regulatory … AGGRASTAT® (tirofiban hydrochloride) injection, ZYPITAMAG® (pitavastatin) tablets, and Marley Drug® are registered …
-
Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
25 Jun 2024 16:38 GMT
… commercialization of pharmaceuticals and healthcare … methods of medical treatment containing P5P Analogues ( … clinical trials and obtaining regulatory … AGGRASTAT® (tirofiban hydrochloride) injection, ZYPITAMAG® (pitavastatin) tablets, and Marley Drug® are …
-
Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
29 May 2024 21:07 GMT
… Medicure Inc.
Medicure is a company focused on the development and commercialization of pharmaceuticals … of clinical trials and obtaining regulatory approval … AGGRASTAT® (tirofiban hydrochloride) injection, ZYPITAMAG® (pitavastatin) tablets, and Marley Drug® are …
-
Intravenous Tirofiban Reduces Neurological Deterioration in Acute Noncardioembolic Stroke: JAMA
24 Apr 2024 20:47 GMT
… experience neurological deterioration despite recommended treatment, which can lead to poor … , open-label, randomized clinical trial enrolled 425 patients aged 18 … … TREND Investigators. (2024). Effects of tirofiban on neurological deterioration in patients …
-
Short-Term Effect of Ambient Temperature in Acute Ischemic Stroke with Endovascular Treatment Due to Large Vessel Occlusion
17 Apr 2024 07:31 GMT
… compares endovascular treatment with and without tirofiban for stroke … 182 received only standard medical treatment, while the remaining … influences platelet count, heart rate, platelet viscosity, … with hospitalizations for cardiovascular diseases and stroke …
-
Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
05 Apr 2024 11:51 GMT
… website.
About Medicure Inc.
Medicure is a pharmaceutical company focused on … U.S. cardiovascular market. The present … of clinical trials and obtaining regulatory approval … ® (tirofiban hydrochloride) injection, ZYPITAMAG® (pitavastatin) tablets, and Marley Drug® are …
-
2023 First Generic Drug Approvals
08 Mar 2024 22:36 GMT
… angiography throughout the cardiovascular system; coronary arteriography … the treatment of NYHA Class III-IV heart … Package
B. Braun Medical, Inc.
Calcium Gluconate … Dose Containers
Nexus Pharmaceuticals, Inc.
Aggrastat (Tirofiban Hydrochloride) Injection
…
-
A Prediction Model Based on Systemic Immune-Inflammatory Index Combined with Other Predictors for Major Adverse Cardiovascular Events in Acute Myocardial Infarction Patients
22 Feb 2024 08:22 GMT
… and improvements in drug treatments have reduced the … medications during hospitalization in our hospital [aspirin, clopidogrel, ticagrelor, tirofiban, anticoagulant drugs, statins … trials: a report of the American College of Cardiology/;American Heart …
-
Poststroke Neurologic Deterioration Reduced With Tirofiban, Study Finds
10 Feb 2024 22:26 GMT
… randomized controlled trial (NCT04491695) showed that treatment with tirofiban, an antiplatelet medication, resulted … Wenbo Zhao, MD, a medical doctor at Xuanwu Hospital in Beijing … Journal of Medicine on the RESCUE BT2 trial assessing tirofiban in patients …
-
Tirofiban Reduces Early Deterioration After Stroke
12 Feb 2024 09:09 GMT
… .org | Medscape Cardiology, conference chair, Tudor Jovin, MD, Cooper Medical School of … in larger trials."
Interestingly, another study, the MOST trial, also presented … days of IV tirofiban, whereas the duration of antithrombotic treatment in MOST …